ID   MYLK3_RAT               Reviewed;         786 AA.
AC   E9PT87; A8WE96;
DT   03-OCT-2012, integrated into UniProtKB/Swiss-Prot.
DT   05-APR-2011, sequence version 1.
DT   02-OCT-2024, entry version 76.
DE   RecName: Full=Myosin light chain kinase 3;
DE            EC=2.7.11.18;
DE   AltName: Full=Cardiac-MyBP-C-associated Ca/CaM kinase;
DE            Short=Cardiac-MLCK;
GN   Name=Mylk3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INDUCTION, AND TISSUE SPECIFICITY.
RC   STRAIN=Wistar;
RX   PubMed=20615916; DOI=10.1093/cvr/cvq223;
RA   Gu X., Liu X., Xu D., Li X., Yan M., Qi Y., Yan W., Wang W., Pan J., Xu Y.,
RA   Xi B., Cheng L., Jia J., Wang K., Ge J., Zhou M.;
RT   "Cardiac functional improvement in rats with myocardial infarction by up-
RT   regulating cardiac myosin light chain kinase with neuregulin.";
RL   Cardiovasc. Res. 88:334-343(2010).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [3]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND DEVELOPMENTAL
RP   STAGE.
RX   PubMed=17885681; DOI=10.1172/jci30804;
RA   Seguchi O., Takashima S., Yamazaki S., Asakura M., Asano Y., Shintani Y.,
RA   Wakeno M., Minamino T., Kondo H., Furukawa H., Nakamaru K., Naito A.,
RA   Takahashi T., Ohtsuka T., Kawakami K., Isomura T., Kitamura S., Tomoike H.,
RA   Mochizuki N., Kitakaze M.;
RT   "A cardiac myosin light chain kinase regulates sarcomere assembly in the
RT   vertebrate heart.";
RL   J. Clin. Invest. 117:2812-2824(2007).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-155; SER-341 AND SER-422, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Calmodulin-dependent kinase that phosphorylates MYL2 in
CC       vitro. Promotes sarcomere formation in cardiomyocytes. Increases
CC       cardiomyocyte contractility. {ECO:0000269|PubMed:17885681,
CC       ECO:0000269|PubMed:20615916}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[myosin light chain] = ADP + H(+) + O-phospho-L-
CC         seryl-[myosin light chain]; Xref=Rhea:RHEA:22004, Rhea:RHEA-
CC         COMP:13684, Rhea:RHEA-COMP:13685, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421,
CC         ChEBI:CHEBI:456216; EC=2.7.11.18;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[myosin light chain] = ADP + H(+) + O-
CC         phospho-L-threonyl-[myosin light chain]; Xref=Rhea:RHEA:53900,
CC         Rhea:RHEA-COMP:13686, Rhea:RHEA-COMP:13687, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977,
CC         ChEBI:CHEBI:456216; EC=2.7.11.18;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17885681}.
CC   -!- TISSUE SPECIFICITY: Expressed in cardiomyocytes (at protein level). Up-
CC       regulated in heart after experimental myocardial infarction at the mRNA
CC       level. {ECO:0000269|PubMed:17885681, ECO:0000269|PubMed:20615916}.
CC   -!- DEVELOPMENTAL STAGE: Up-regulated in the heart from 1 week after birth
CC       through adulthood. {ECO:0000269|PubMed:17885681}.
CC   -!- INDUCTION: by NRG1 (at protein level). {ECO:0000269|PubMed:20615916}.
CC   -!- PTM: Phosphorylated on serine residues. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EU236721; ABW96144.1; -; mRNA.
DR   RefSeq; NP_001104280.1; NM_001110810.1.
DR   AlphaFoldDB; E9PT87; -.
DR   SMR; E9PT87; -.
DR   BioGRID; 253688; 1.
DR   STRING; 10116.ENSRNOP00000023657; -.
DR   iPTMnet; E9PT87; -.
DR   PhosphoSitePlus; E9PT87; -.
DR   jPOST; E9PT87; -.
DR   PaxDb; 10116-ENSRNOP00000023657; -.
DR   PeptideAtlas; E9PT87; -.
DR   Ensembl; ENSRNOT00000023657.7; ENSRNOP00000023657.5; ENSRNOG00000017546.8.
DR   GeneID; 291926; -.
DR   KEGG; rno:291926; -.
DR   AGR; RGD:1305801; -.
DR   CTD; 91807; -.
DR   RGD; 1305801; Mylk3.
DR   eggNOG; KOG0032; Eukaryota.
DR   GeneTree; ENSGT00940000160007; -.
DR   HOGENOM; CLU_000288_90_0_1; -.
DR   InParanoid; E9PT87; -.
DR   OMA; IHVQEMD; -.
DR   OrthoDB; 5402680at2759; -.
DR   TreeFam; TF314166; -.
DR   PRO; PR:E9PT87; -.
DR   Proteomes; UP000002494; Chromosome 19.
DR   Bgee; ENSRNOG00000017546; Expressed in heart and 7 other cell types or tissues.
DR   GO; GO:0015629; C:actin cytoskeleton; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; IDA:BHF-UCL.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004683; F:calmodulin-dependent protein kinase activity; IDA:BHF-UCL.
DR   GO; GO:0004687; F:myosin light chain kinase activity; IMP:BHF-UCL.
DR   GO; GO:0055003; P:cardiac myofibril assembly; IMP:BHF-UCL.
DR   GO; GO:0071347; P:cellular response to interleukin-1; ISO:RGD.
DR   GO; GO:0060298; P:positive regulation of sarcomere organization; IDA:BHF-UCL.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:BHF-UCL.
DR   GO; GO:0002528; P:regulation of vascular permeability involved in acute inflammatory response; ISO:RGD.
DR   GO; GO:0045214; P:sarcomere organization; IMP:BHF-UCL.
DR   GO; GO:0048769; P:sarcomerogenesis; IMP:BHF-UCL.
DR   CDD; cd14192; STKc_MLCK3; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24342:SF15; DEATH-ASSOCIATED PROTEIN KINASE 2; 1.
DR   PANTHER; PTHR24342; SERINE/THREONINE-PROTEIN KINASE 17; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cytoplasm; Kinase; Magnesium; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN           1..786
FT                   /note="Myosin light chain kinase 3"
FT                   /id="PRO_0000419665"
FT   DOMAIN          482..737
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          233..258
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          279..315
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          333..443
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        279..296
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        603
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         488..496
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         511
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         155
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         341
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         422
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CONFLICT        244
FT                   /note="T -> A (in Ref. 1; ABW96144)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   786 AA;  85541 MW;  3355DA69E4FCBB26 CRC64;
     MSGVSEEDPE GLGPQGLPAL GGACLVTVDK KLNVLTEKVD RLLHFQEDVT EKLQCVCQGM
     DHLEQGLHRL EASQELGLAG PGSTSPAAAQ AAWPEVLELV RAVRQEGAQH GARLEALFKM
     VVAVDRAITL VGSTIQNSKV DDFILQGTVP WRKGSLADGP EENKEQAEVA GVKPKHVLNT
     GSVQAATSRA LWEESQKQDT PVGTVEGLPL IIDTSLKGAD LTQAGASLRQ GVEALDPGQE
     PPPTEAESRL PALASEDTGT TLELSVAIDR ISEVLTSLRM SQSAGEGTSS SKPDCSEPGP
     QPLGPLTTDS DIHSDEGLPR ISVRMREMTT PEELFETQGG SPIGSAEAPG PGTVLEDQIP
     KGARPFPPLP KRSCNNGGAS AEEATGPGAE PIRGPSLVTR DWRDEPVGTT DLQQGRDPGA
     VSPEPGKDHA AQGPGRTEAG RRVSSAAEAA IVVLDDSAAP PAPFEHRVVS IKDTLISTSY
     TVSQHEVLGG GRFGQVHRCT ERSTGLALAA KIIKVKNIKD REDVKNEINI MNQLSHVNLI
     QLYDAFESKN SFTLIMEYVD GGELFDRITD EKYHLTELDV VLFTRQICEG VHYLHQHYIL
     HLDLKPENIL CVSQTGHQIK IIDFGLARRY KPREKLKVNF GTPEFLAPEV VNYEFVSFPT
     DMWSVGVITY MLLSGLSPFL GETDAETMNF IVNCSWDFDA DTFKGLSEEA KDFVSRLLVK
     EKSCRMSATQ CLKHEWLNHL IAKASGSNVR LRSQLLLQKY MAQRKWKKHF HVVTAVNRLR
     KFPTCP
//
